NCT01220921
Completed
Phase 3
Neurosurgery Patient Outcomes in Treating Spinal Disorders
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Symptomatic Lumbar Disc Herniation
- Sponsor
- Greenwich Hospital
- Enrollment
- 198
- Locations
- 13
- Primary Endpoint
- Site and Physician Compliance
- Status
- Completed
- Last Updated
- 10 years ago
Overview
Brief Summary
The creation of a multi-center cooperative research group encompassing academic and community-based spinal practices . . .
Investigators
Eligibility Criteria
Inclusion Criteria
- •Grade I degenerative or isthmic spondylolisthesis recalcitrant to non-invasive therapies for at least 3 months or Lumbar degenerative disc herniation with radiculopathy refractory to non-invasive therapies for at least 6 weeks
Exclusion Criteria
- •History of previous lumbar spine surgery
- •Significant motor weakness (3/5) (i.e. foot drop)
- •Cancer, infection, or fracture
- •Pregnancy
Outcomes
Primary Outcomes
Site and Physician Compliance
Time Frame: 1 Year
Goal = 80% compliance in enrolling 20 patients over 1 year with completed outcomes instruments
SF-36 version 1
Time Frame: 1-Year
Health-realted quality of life outcome measure
Secondary Outcomes
- Oswestry Disability Index (ODI)(1 Year)
- Visual Analog Pain Score(1 Year)
- Return to Work(1 Year)
- 30 day complications(30 days)
- Delayed Surgical Complications(1 year)
Study Sites (13)
Loading locations...
Similar Trials
Completed
Not Applicable
Multi-center Project: Spinal Abnormalities in Neurofibromatosis Type1 (NF1) PatientsNeurofibromatosis Type 1NCT00667836Shriners Hospitals for Children300
Completed
Not Applicable
A Multi-Centre Clinical Study in Spinal Cord Injury Patients in Mainland China and Hong KongSpinal Cord InjuriesNCT00517374China Spinal Cord Injury Network600
Completed
Not Applicable
A Multi-Centre Clinical Study in Chronic Spinal Cord Injury PatientsSpinal Cord InjuriesNCT00592722China Spinal Cord Injury Network60
Completed
Phase 3
A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Known or Suspected Brain or Spinal Cord-related ProblemsContrast Enhancement in Magnetic Resonance ImagingCentral Nervous System PathologyNCT05915702Bayer303
Terminated
Not Applicable
Interbody Systems: Post Market Clinical Follow-up StudyDegenerative Disc DiseaseNCT04911257K2M, Inc.28